The Association of Pioglitazone and Urinary Tract Disease in Type 2 Diabetic Taiwanese: Bladder Cancer and Chronic Kidney Disease

Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study

(2012) A. Neumann et al.   DIABETOLOGIA

Risk of Bladder Cancer Among Diabetic Patients Treated With Pioglitazone: Interim report of a longitudinal cohort study

(2011) J. D. Lewis et al.   DIABETES CARE

Assessing the Association of Pioglitazone Use and Bladder Cancer Through Drug Adverse Event Reporting

(2011) C. Piccinni et al.   DIABETES CARE

Association of CKD and Cancer Risk in Older People

(2009) G. Wong et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

FOXA1 and IRF-1 intermediary transcriptional regulators of PPARγ-induced urothelial cytodifferentiation

(2008) C L Varley et al.   CELL DEATH AND DIFFERENTIATION

Effects of PPAR agonists on proliferation and differentiation in human urothelium

(2008) Claire L. Varley et al.   EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY

Association of Albuminuria and Cancer Incidence

(2008) L. Jorgensen et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

The Role of PPARs in Cancer

(2008) Keisuke Tachibana et al.   PPAR Research

Effect of Pioglitazone on Cardiovascular Outcome in Diabetes and Chronic Kidney Disease

(2007) C. A. Schneider et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY